Both in Biotechnology
Cullinan Therapeutics vs Candel Therapeutics
Over the past year CGEM returned +64.6% and CADL returned +53.7%; their daily moves had a correlation of 0.36.
CGEM +64.6% CADL +53.7%Growth of $1, one year, split-adjusted
| Metric | CGEM | CADL |
|---|---|---|
| Price | $12.93 | $8.19 |
| Market cap | $832.1M | $626.7M |
| Today | −7.64% | −8.08% |
| 1 month | −39.5% | −27.8% |
| 6 months | −14.1% | +28.6% |
| Year to date | +24.9% | +45.0% |
| 1 year | +49.8% | +37.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $334.5M | $153.7M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 63.7% |
| Short % of float | 14.3% | 23.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).